Literature DB >> 27778300

Liver Perfusion Modifies Gd-DTPA and Gd-BOPTA Hepatocyte Concentrations Through Transfer Clearances Across Sinusoidal Membranes.

Jean-Luc Daire1, Benjamin Leporq2, Valérie Vilgrain1,2,3, Bernard E Van Beers1,2,3, Sabine Schmidt4, Catherine M Pastor5,6,7.   

Abstract

BACKGROUND AND OBJECTIVES: Gadobenate dimeglumine (Gd-BOPTA) is a commercialised hepatobiliary contrast agent used during liver magnetic resonance imaging (MRI) to detect liver diseases. It enters into human hepatocytes through organic anion transporting polypeptides (OATP1B1/B3) and crosses the canalicular transporter multiple resistance-associated protein 2 (MRP2) to be excreted into bile canaliculi. Gd-BOPTA can return to sinusoids via the sinusoidal transporters MRP3/MRP4. Hepatocyte concentrations of Gd-BOPTA depend on three clearances: the sinusoidal clearance or volume of sinusoidal blood cleared of drugs per unit of time and two hepatocyte clearances (into bile canaliculi or back to sinusoids) or volume of hepatocytes cleared of drugs per unit of time in the respective liver compartments. The present study investigates whether changing liver blood flow modifies hepatocyte concentrations when plasma concentrations do not change.
METHODS: We perfused normal rat livers at various portal flow rates (24, 30, and 36 ml/min) with 200 µM Gd-BOPTA and measured sinusoidal clearances, hepatocyte clearances, and hepatocyte concentrations of Gd-BOPTA.
RESULTS: We showed that varying portal flow rates changes the sinusoidal clearance of Gd-BOPTA despite its low extraction ratio. Portal flow rates do not modify Gd-BOPTA clearance from hepatocytes into bile canaliculi but can change hepatocyte clearance back to sinusoids.
CONCLUSION: At a given perfused concentration, portal flow rates modify Gd-BOPTA hepatocyte concentrations, a result important to consider when interpreting liver imaging.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27778300     DOI: 10.1007/s13318-016-0382-x

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  26 in total

Review 1.  An integrated approach to model hepatic drug clearance.

Authors:  Lichuan Liu; K Sandy Pang
Journal:  Eur J Pharm Sci       Date:  2006-05-22       Impact factor: 4.384

Review 2.  In vitro methods to support transporter evaluation in drug discovery and development.

Authors:  K L R Brouwer; D Keppler; K A Hoffmaster; D A J Bow; Y Cheng; Y Lai; J E Palm; B Stieger; R Evers
Journal:  Clin Pharmacol Ther       Date:  2013-04-10       Impact factor: 6.875

3.  Direct evidence of the temperature dependence of Gd-BOPTA transport in the intact rat liver.

Authors:  Corinne Planchamp; Gerd J Beyer; Daniel O Slosman; François Terrier; Catherine M Pastor
Journal:  Appl Radiat Isot       Date:  2005-01-07       Impact factor: 1.513

Review 4.  Biliary physiology and disease: reflections of a physician-scientist.

Authors:  Gustav Paumgartner
Journal:  Hepatology       Date:  2010-04       Impact factor: 17.425

5.  Diagnostic and pathogenetic implications of the expression of hepatic transporters in focal lesions occurring in normal liver.

Authors:  Sara Vander Borght; Louis Libbrecht; Hans Blokzijl; Klaas Nico Faber; Han Moshage; Raymond Aerts; Werner Van Steenbergen; Peter L Jansen; Valeer J Desmet; Tania A Roskams
Journal:  J Pathol       Date:  2005-12       Impact factor: 7.996

6.  Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging--correlation with molecular transporters and histopathologic features.

Authors:  Azusa Kitao; Yoh Zen; Osamu Matsui; Toshifumi Gabata; Satoshi Kobayashi; Wataru Koda; Kazuto Kozaka; Norihide Yoneda; Tatsuya Yamashita; Shuichi Kaneko; Yasuni Nakanuma
Journal:  Radiology       Date:  2010-07-27       Impact factor: 11.105

7.  How transfer rates generate Gd-BOPTA concentrations in rat liver compartments: implications for clinical liver imaging with hepatobiliary contrast agents.

Authors:  Catherine M Pastor
Journal:  Contrast Media Mol Imaging       Date:  2016-04-05       Impact factor: 3.161

8.  Beta-catenin-activated hepatocellular adenoma showing hyperintensity on hepatobiliary-phase gadoxetic-enhanced magnetic resonance imaging and overexpression of OATP8.

Authors:  Norihide Yoneda; Osamu Matsui; Azusa Kitao; Kazuto Kozaka; Toshifumi Gabata; Motoko Sasaki; Yasuni Nakanuma; Kiyoshi Murata; Toru Tani
Journal:  Jpn J Radiol       Date:  2012-08-23       Impact factor: 2.374

9.  Effect of hepatic venous outflow obstruction on pores and fenestration in sinusoidal endothelium.

Authors:  W Nopanitaya; J C Lamb; J W Grisham; J L Carson
Journal:  Br J Exp Pathol       Date:  1976-10

10.  Distribution of organelles and membranes between hepatocytes and nonhepatocytes in the rat liver parenchyma. A stereological study.

Authors:  A Blouin; R P Bolender; E R Weibel
Journal:  J Cell Biol       Date:  1977-02       Impact factor: 10.539

View more
  3 in total

1.  Application of ultrasound combined with enhanced MRI by Gd-BOPTA in diagnosing hepatocellular carcinoma.

Authors:  Shuwen Ji; Ziyong Wang; Shiyong Xia
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

2.  Isolated Perfused Rat Livers to Quantify the Pharmacokinetics and Concentrations of Gd-BOPTA.

Authors:  Catherine M Pastor
Journal:  Contrast Media Mol Imaging       Date:  2018-07-11       Impact factor: 3.161

3.  Portal hypertension may influence the registration of hypointensity of small hepatocellular carcinoma in the hepatobiliary phase in gadoxetic acid MR.

Authors:  Carla Caparroz; Alejandro Forner; Jordi Rimola; Anna Darnell; Ángeles García-Criado; Juan Ramón Ayuso; María Reig; Jordi Bruix; Carmen Ayuso
Journal:  Radiol Oncol       Date:  2022-08-14       Impact factor: 4.214

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.